Education
High School Vincenzo Guerrisi High School Cittanova, RC Italy 1981
Medical Doctor University of Messina, Italy July 1987
General Surgery University of Messina, Italy October 1992
Oncology University of Paris IX, France 1993

Clinical Experience
Associated Researcher Dept. of Surgery at the "National Cancer Institute of Milan", Italy 1989-1991/1994-1998
Associated Researcher Dept. of Surgery at the "Gustave Roussy Institut" Villejuif, France 1991-1993
Associated Researcher Dept. of Surgery at "The Royal Marsden Hospital" London, UK 1993
Visiting MD Dept. of Surgery "Washington Cancer Institute at the Washington Hospital Center", Washington DC USA 1996
Current Position: Attending Surgeon Department of Surgery at the National Cancer Institute of Milan, Italy

Membership and Secretary
SITILO Società Italiana di Terapie Integrate Loco-Regionali in Oncologia (Italian Society for Loco Regional Cancer Therapy)

Membership
SIC Società Italiana di Chirurgia
SICO Società Italiana di Chirurgia Oncologica
ISRCT International Society for Regional Cancer Therapy
Licensure
European Community

Participation in National Protocols at the National Cancer Institute of Milan
- "Evaluation of cytoreductive surgery (peritonectomy) and intra peritoneal hyperthermic perfusion in patients affected by pseudomyxoma peritonei or mesothelioma. A phase II clinical study". Study of AIRC 1998-2000.
- "Intra Peritoneal Hyperthermic Perfusion with Doxorubicin and cis-Platin. A multicentric phase I Clinical Study".
- "Primary Chemotherapy for Locally advanced Gastric Carcinoma".
- "Treatment of locally advanced gastric cancer by radical surgery and intra peritoneal hypertermic perfusion. A multicentric phase II clinical study."
- "Stop-Flow perfusion with Adryamicin + Mitomycin C in the treatment of rectal cancer recurrence. Phase II clinical study."
- "Intergrups Italian Study, Non resectable pancreatic cancer: Systemic Chemotherapy with 5-FU vs Systemic Chemotherapy with Gemcitabin vs Loco-Regional Chemotherapy with FLEC. A multicentric SITILO randomised clinical study."
- "A Phase I/II study of active specific immunotherapy in patients with metastatic melanoma using autologous tumor-derived, Heat Shock Protein Peptide Complex-96 (HSPPC-96), vaccine."

Many important pubblications